Vir Biotechnology, Inc. - Common Stock (NQ:VIR)

9.321 -0.969 (-9.42%)

Streaming Delayed Price Updated: 3:17 PM EDT, May 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vir Biotechnology, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors

April 18, 2024

From Vir Biotechnology, Inc.

Via Business Wire

Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024

April 11, 2024

From Vir Biotechnology, Inc.

Via Business Wire

From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires ↗

March 19, 2024

These biotech stocks to buy offer a gateway to long-term gains, on the back of groundbreaking healthcare innovations.

Via InvestorPlace

Assessing Vir Biotechnology: Insights From 5 Financial Analysts ↗

March 15, 2024

Via Benzinga

Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio ↗

March 13, 2024

One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses.

Via InvestorPlace

Recap: Vir Biotechnology Q4 Earnings ↗

February 22, 2024

Via Benzinga

Earnings Outlook For Vir Biotechnology ↗

February 21, 2024

Via Benzinga

JP Morgan Downgrades Vir Biotechnology: Here's What You Need To Know ↗

January 29, 2024

Via Benzinga

Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule

March 05, 2024

From Vir Biotechnology, Inc.

Via Business Wire

3 Highly Rated Biotech Stocks to Buy for 300% Gains ↗

February 26, 2024

Biotech stocks like those discussed here have the potential to produce 300% returns and benefit from high analyst ratings.

Via InvestorPlace

Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday ↗

February 23, 2024

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday.

Via Benzinga

Topics Stocks

Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences

February 23, 2024

From Vir Biotechnology, Inc.

Via Business Wire

Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 23, 2024

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results.

Via Benzinga

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

February 22, 2024

From Vir Biotechnology, Inc.

Via Business Wire

Earnings Scheduled For February 22, 2024 ↗

February 22, 2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.

Via Benzinga

Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer

February 20, 2024

From Vir Biotechnology, Inc.

Via Business Wire

3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave ↗

February 14, 2024

Explore hidden-gem biotech stocks set for growth in a booming market. Uncover top picks ready to redefine healthcare innovation.

Via InvestorPlace

Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024

February 01, 2024

From Vir Biotechnology, Inc.

Via Business Wire

HC Wainwright & Co. Maintains Buy Rating for Vir Biotechnology: Here's What You Need To Know ↗

January 23, 2024

Via Benzinga

COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs ↗

December 20, 2023

COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023.&n

Via Benzinga

Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation

December 13, 2023

From Vir Biotechnology, Inc.

Via Business Wire

Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference

December 06, 2023

From Vir Biotechnology, Inc.

Via Business Wire

7 Small-Cap Stocks to Buy BEFORE the Year-End Rally ↗

November 30, 2023

explore and wager on these top small-cap stocks to buy, poised for significant gains in today's dynamic global economy

Via InvestorPlace

From laggards to leaders: Small caps on the rise

November 27, 2023

Despite large-cap dominance, signs suggest a shift to small-cap leadership. Valuations, positive Q3 results, and historical patterns point to potential gains.

Via MarketBeat

Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023

November 13, 2023

From Vir Biotechnology, Inc.

Via Business Wire

Vir Biotechnology to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B and Delta Trials at AASLD’s The Liver Meeting® 2023

November 10, 2023

From Vir Biotechnology, Inc.

Via Business Wire

Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™

November 08, 2023

From Vir Biotechnology, Inc.

Via Business Wire

Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results

November 02, 2023

From Vir Biotechnology, Inc.

Via Business Wire

Vir Biotechnology Appoints Jennifer Towne, Ph.D., as Executive Vice President and Chief Scientific Officer

October 30, 2023

From Vir Biotechnology, Inc.

Via Business Wire

Earnings Scheduled For November 2, 2023 ↗

November 02, 2023

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.